Lupin shares touch 52-week high as Q1 profit surges 77%
Lupin deals in branded and generic formulations, active pharmaceutical ingredients (APIs), and biosimilars.
lupin shares
August 2024
November 2023
September 2023
August 2023
March 2023
Lupin shares hit 52-week high on strong Q2 results
The company's revenue from operations in the Q2 of FY24, stood at ₹5,038.6 crore, up 21.5% YoY as against ₹4,145.5 crore in the same period last year.
Lupin shares hit 52-week high on plans to transfer two APIs, select R&D operations to LMSL
The share price of the company surged as much as 4.08% to hit a 52-week high of ₹1,174.00 in early session.
Lupin shares rise 2% on launching heart drug in Canada
The pharma major’s subsidiary has launched Propranolol LA capsules, 60 mg, 80 mg, 120 mg, and 160 mg, in Canada.
Lupin shares dip 4% on US FDA observations for Pithampur unit
The U.S. drug regulator has issued Form 483 with ten observations for Lupin’s Pithampur unit-2 manufacturing facility.
